106 related articles for article (PubMed ID: 15167270)
1. The serotonin transporter is present and functional in peripheral arterial smooth muscle.
Ni W; Thompson JM; Northcott CA; Lookingland K; Watts SW
J Cardiovasc Pharmacol; 2004 Jun; 43(6):770-81. PubMed ID: 15167270
[TBL] [Abstract][Full Text] [Related]
2. Arterial 5-hydroxytryptamine transporter function is impaired in deoxycorticosterone acetate and Nomega-nitro-L-arginine but not spontaneously hypertensive rats.
Ni W; Lookingland K; Watts SW
Hypertension; 2006 Jul; 48(1):134-40. PubMed ID: 16754787
[TBL] [Abstract][Full Text] [Related]
3. Serotonin-induced contraction in mesenteric resistance arteries: signaling and changes in deoxycorticosterone acetate-salt hypertension.
Watts SW
Hypertension; 2002 Mar; 39(3):825-9. PubMed ID: 11897772
[TBL] [Abstract][Full Text] [Related]
4. 5-Hydroxytryptamine2B receptor mediates contraction in the mesenteric artery of mineralocorticoid hypertensive rats.
Watts SW; Gilbert L; Webb RC
Hypertension; 1995 Dec; 26(6 Pt 2):1056-9. PubMed ID: 7498967
[TBL] [Abstract][Full Text] [Related]
5. PI3-kinase upregulation and involvement in spontaneous tone in arteries from DOCA-salt rats: is p110delta the culprit?
Northcott CA; Hayflick JS; Watts SW
Hypertension; 2004 Apr; 43(4):885-90. PubMed ID: 14993194
[TBL] [Abstract][Full Text] [Related]
6. The 5-hydroxytryptamine2B receptor and 5-HT receptor signal transduction in mesenteric arteries from deoxycorticosterone acetate-salt hypertensive rats.
Watts SW; Baez M; Webb RC
J Pharmacol Exp Ther; 1996 May; 277(2):1103-13. PubMed ID: 8627522
[TBL] [Abstract][Full Text] [Related]
7. (+)-Norfenfluramine-induced arterial contraction is not dependent on endogenous 5-hydroxytryptamine or 5-hydroxytryptamine transporter.
Ni W; Wilhelm CS; Bader M; Murphy DL; Lookingland K; Watts SW
J Pharmacol Exp Ther; 2005 Sep; 314(3):953-60. PubMed ID: 15901794
[TBL] [Abstract][Full Text] [Related]
8. Enhanced contraction to 5-hydroxytryptamine is not due to "unmasking" of 5-hydroxytryptamine(1b) receptors in the mesenteric artery of the deoxycorticosterone acetate-salt rat.
Banes AK; Watts SW
Hypertension; 2001 Oct; 38(4):891-5. PubMed ID: 11641304
[TBL] [Abstract][Full Text] [Related]
9. Induction of serotonin transporter by hypoxia in pulmonary vascular smooth muscle cells. Relationship with the mitogenic action of serotonin.
Eddahibi S; Fabre V; Boni C; Martres MP; Raffestin B; Hamon M; Adnot S
Circ Res; 1999 Feb; 84(3):329-36. PubMed ID: 10024307
[TBL] [Abstract][Full Text] [Related]
10. Endothelin-1-induced venous contraction is maintained in DOCA-salt hypertension; studies with receptor agonists.
Watts SW; Fink GD; Northcott CA; Galligan JJ
Br J Pharmacol; 2002 Sep; 137(1):69-79. PubMed ID: 12183332
[TBL] [Abstract][Full Text] [Related]
11. 5-hydroxytryptamine (5-HT) reduces total peripheral resistance during chronic infusion: direct arterial mesenteric relaxation is not involved.
Davis RP; Pattison J; Thompson JM; Tiniakov R; Scrogin KE; Watts SW
BMC Pharmacol; 2012 May; 12():4. PubMed ID: 22559843
[TBL] [Abstract][Full Text] [Related]
12. Sarcoplasmic reticulum Ca2+ uptake is not decreased in aorta from deoxycorticosterone acetate hypertensive rats: functional assessment with cyclopiazonic acid.
Tostes RC; Traub O; Bendhack LM; Webb RC
Can J Physiol Pharmacol; 1995 Nov; 73(11):1536-45. PubMed ID: 8789405
[TBL] [Abstract][Full Text] [Related]
13. Enhancement of receptor-operated cation current and TRPC6 expression in arterial smooth muscle cells of deoxycorticosterone acetate-salt hypertensive rats.
Bae YM; Kim A; Lee YJ; Lim W; Noh YH; Kim EJ; Kim J; Kim TK; Park SW; Kim B; Cho SI; Kim DK; Ho WK
J Hypertens; 2007 Apr; 25(4):809-17. PubMed ID: 17351373
[TBL] [Abstract][Full Text] [Related]
14. Serotonin-induced smooth muscle hyperplasia in various forms of human pulmonary hypertension.
Marcos E; Fadel E; Sanchez O; Humbert M; Dartevelle P; Simonneau G; Hamon M; Adnot S; Eddahibi S
Circ Res; 2004 May; 94(9):1263-70. PubMed ID: 15059929
[TBL] [Abstract][Full Text] [Related]
15. Serotonin-induced ion channel modulations in mesenteric artery myocytes from normotensive and DOCA-salt hypertensive rats.
Bae YM; Sung DJ; Noh HJ; Kim J; Park SW; Kim B; Cho SI
J Smooth Muscle Res; 2007 Jun; 43(3):85-97. PubMed ID: 17721045
[TBL] [Abstract][Full Text] [Related]
16. 5-HT2B-receptor antagonist LY-272015 is antihypertensive in DOCA-salt-hypertensive rats.
Watts SW; Fink GD
Am J Physiol; 1999 Mar; 276(3):H944-52. PubMed ID: 10070078
[TBL] [Abstract][Full Text] [Related]
17. Upregulation of arterial serotonin 1B and 2B receptors in deoxycorticosterone acetate-salt hypertension.
Banes AK; Watts SW
Hypertension; 2002 Feb; 39(2 Pt 2):394-8. PubMed ID: 11882579
[TBL] [Abstract][Full Text] [Related]
18. The development of enhanced arterial serotonergic hyperresponsiveness in mineralocorticoid hypertension.
Watts SW
J Hypertens; 1998 Jun; 16(6):811-22. PubMed ID: 9663921
[TBL] [Abstract][Full Text] [Related]
19. Differential alterations in sympathetic neurotransmission in mesenteric arteries and veins in DOCA-salt hypertensive rats.
Luo M; Hess MC; Fink GD; Olson LK; Rogers J; Kreulen DL; Dai X; Galligan JJ
Auton Neurosci; 2003 Feb; 104(1):47-57. PubMed ID: 12559203
[TBL] [Abstract][Full Text] [Related]
20. The existence of a local 5-hydroxytryptaminergic system in peripheral arteries.
Ni W; Geddes TJ; Priestley JR; Szasz T; Kuhn DM; Watts SW
Br J Pharmacol; 2008 Jun; 154(3):663-74. PubMed ID: 18414394
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
